journal article·2026-05Open access

PVN CRF Neurons Regulate Migraine‐Like Allodynia by Activating CRFR2 on Spinal Trigeminal Caudalis Glutamatergic Neurons

Jiang Bian, Xiao‐Long Wang, Li Yin, Wei Wei, Xue Li, Yao Ge, Zhao‐Xia Xiang, Na Tian, Li‐Juan Chen, Ming‐Wei Ma, Xia Zhang, Xu Jing, Mei‐Yun Wang, Xu‐Feng Xu

Advanced Science· Volume 13· Issue 29

Abstract

ABSTRACT Migraine is a prevalent and debilitating neurological disorder with poorly understood neural mechanisms. Here, we characterize a hypothalamic‐trigeminal pathway involved in the regulation of migraine‐like allodynia. Using a combination of monosynaptic circuit, fiber photometry‐based calcium imaging, and behavioral assays in a nitroglycerin (NTG)‐induced murine model, we observed hyperactivity in corticotropin‐releasing factor (CRF)‐expressing neurons within the hypothalamic paraventricular nucleus (PVN). Activation or inhibition of PVN CRF neurons mimicked or blocked migraine‐like allodynia, respectively. These PVN CRF neurons modulated migraine‐like allodynia by exciting glutamatergic neurons in the spinal trigeminal nucleus caudalis (SP5C). Furthermore, employing a CRF neurotransmitter fluorescent sensor, neuropharmacology, and electrophysiological recordings, we revealed that PVN CRF neurons excessively release CRF neuropeptides onto SP5C Glu neurons during migraine‐like conditions. This led to hyperactivation of corticotropin‐releasing factor receptor type 2 (CRFR2), but not type 1 (CRFR1), resulting in hyperalgesia. Blockade of CRFR2 within the SP5C significantly alleviated migraine‐like allodynia. Complementing these findings, clinical functional magnetic resonance imaging (fMRI) of migraine patients indicated structural and functional alterations in PVN and SP5C regions associated with this pathway. Collectively, our results uncover a previously unappreciated PVN CRF ‐SP5C Glu pathway in migraine‐like allodynia, providing novel insights into the neurobiology of migraine and identifying potential therapeutic targets.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Migraine and Headache Studies · Neuroendocrine regulation and behavior · Stress Responses and Cortisol

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Neuropsychiatry Research Institute, Basic School of Medicine The Affiliated Hospital of Qingdao University Qingdao University Qingdao China

Department of Anesthesiology Panzhihua Central Hospital Panzhihua China

Department of Breast Surgery General Surgery Qilu Hospital of Shandong University Jinan Shandong China

Department of Radiology Henan Provincial People's Hospital & State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer Zhengzhou University Zhengzhou Henan China

Department of Neurology Henan Provincial People's Hospital Zhengzhou University Zhengzhou Henan China

Department of Microbiology, Tumor and Cell Biology Karolinska Institute Stockholm Sweden

Breast Disease Center The First Affiliated Hospital, Sun Yat‐sen University Guangzhou China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province

References (67)

Show source-provided references
1. 10.1016/S1474-4422(18)30322-310.1016/S1474-4422(18)30322-3 ↗
2. 10.1016/S0140‐6736(20)30925‐910.1016/S0140‐6736(20)30925‐9 ↗
3. 10.1186/s10194‐023‐01705‐y10.1186/s10194‐023‐01705‐y ↗
4. 10.1002/hbm.2608510.1002/hbm.26085 ↗
5. 10.1093/brain/awac10410.1093/brain/awac104 ↗
6. 10.1212/WNL.000000000000396310.1212/WNL.0000000000003963 ↗
7. 10.1177/033310242092000510.1177/0333102420920005 ↗
8. 10.1177/0333102423115808810.1177/03331024231158088 ↗
9. 10.1186/s10194‐020‐01210‐610.1186/s10194‐020‐01210‐6 ↗
10. 10.1113/JP28836610.1113/JP288366 ↗
11. 10.1016/j.neuron.2023.03.01410.1016/j.neuron.2023.03.014 ↗
12. 10.1038/s41386‐023‐01678‐110.1038/s41386‐023‐01678‐1 ↗
13. 10.1523/JNEUROSCI.2624‐09.200910.1523/JNEUROSCI.2624‐09.2009 ↗
14. 10.1523/JNEUROSCI.1501-23.202410.1523/JNEUROSCI.1501-23.2024 ↗
15. 10.1016/j.pain.2013.10.00410.1016/j.pain.2013.10.004 ↗
16. 10.1177/033310241986172610.1177/0333102419861726 ↗
17. 10.1016/B978-0-12-823357-3.00024-010.1016/B978-0-12-823357-3.00024-0 ↗
18. 10.1177/033310241987766210.1177/0333102419877662 ↗
19. 10.1186/s10194‐024‐01855‐710.1186/s10194‐024‐01855‐7 ↗
20. 10.3389/fneur.2021.83103510.3389/fneur.2021.831035 ↗
21. 10.1523/JNEUROSCI.0439‐13.201310.1523/JNEUROSCI.0439‐13.2013 ↗
22. 10.1002/cne.2545110.1002/cne.25451 ↗
23. 10.1038/s41467‐022‐35355‐610.1038/s41467‐022‐35355‐6 ↗
24. 10.1038/nrn.2016.6810.1038/nrn.2016.68 ↗
25. 10.1016/j.neuroscience.2016.08.01410.1016/j.neuroscience.2016.08.014 ↗
26. 10.1016/j.celrep.2021.10941110.1016/j.celrep.2021.109411 ↗
27. 10.1126/sciadv.adk763610.1126/sciadv.adk7636 ↗
28. 10.1126/science.abq817310.1126/science.abq8173 ↗
29. 10.1016/j.cell.2009.09.02810.1016/j.cell.2009.09.028 ↗
30. 10.1016/j.molmed.2010.02.00410.1016/j.molmed.2010.02.004 ↗
31. 10.1016/j.biopsych.2016.03.210610.1016/j.biopsych.2016.03.2106 ↗
32. 10.1111/jne.1244010.1111/jne.12440 ↗
33. 10.1084/jem.2016192410.1084/jem.20161924 ↗
34. 10.1053/j.gastro.2011.01.03910.1053/j.gastro.2011.01.039 ↗
35. 10.1016/j.brainres.2005.12.03410.1016/j.brainres.2005.12.034 ↗
36. 10.1016/j.xcrm.2025.10234810.1016/j.xcrm.2025.102348 ↗
37. 10.1016/j.neuron.2021.11.02810.1016/j.neuron.2021.11.028 ↗
38. 10.1016/j.neuron.2024.09.01410.1016/j.neuron.2024.09.014 ↗
39. 10.1111/cns.1438910.1111/cns.14389 ↗
40. 10.1186/s10194‐020‐1079‐810.1186/s10194‐020‐1079‐8 ↗
41. 10.1177/033310241983308710.1177/0333102419833087 ↗
42. 10.1016/B978-0-12-823356-6.00018-410.1016/B978-0-12-823356-6.00018-4 ↗
43. 10.1038/s41593‐024‐01816‐y10.1038/s41593‐024‐01816‐y ↗
44. 10.1016/j.celrep.2024.11466910.1016/j.celrep.2024.114669 ↗
45. 10.1186/s12974‐022‐02498‐810.1186/s12974‐022‐02498‐8 ↗
46. 10.1016/j.neuron.2025.02.02810.1016/j.neuron.2025.02.028 ↗
47. 10.1016/S0304‐3959(03)00302‐610.1016/S0304‐3959(03)00302‐6 ↗
48. 10.1210/en.2014‐142110.1210/en.2014‐1421 ↗
49. 10.1523/JNEUROSCI.1492‐17.201710.1523/JNEUROSCI.1492‐17.2017 ↗
50. 10.1016/j.cub.2023.12.04610.1016/j.cub.2023.12.046 ↗
51. 10.1016/j.neuropharm.2023.10950610.1016/j.neuropharm.2023.109506 ↗
52. 10.1523/JNEUROSCI.2080‐18.201810.1523/JNEUROSCI.2080‐18.2018 ↗
53. 10.1007/s00213‐024‐06693‐810.1007/s00213‐024‐06693‐8 ↗
54. 10.1002/brb3.278310.1002/brb3.2783 ↗
55. 10.1002/j.1532‐2149.2011.00071.x10.1002/j.1532‐2149.2011.00071.x ↗
56. 10.1016/j.molcel.2020.01.01310.1016/j.molcel.2020.01.013 ↗
57. 10.1016/j.molcel.2020.01.01210.1016/j.molcel.2020.01.012 ↗
58. 10.1016/j.neubiorev.2024.10574810.1016/j.neubiorev.2024.105748 ↗
59. 10.1186/s10194‐024‐01753‐y10.1186/s10194‐024‐01753‐y ↗
60. 10.1093/brain/awt25110.1093/brain/awt251 ↗
61. 10.1186/s10194‐019‐0968‐110.1186/s10194‐019‐0968‐1 ↗
62. 10.1016/0165‐0270(94)90144‐910.1016/0165‐0270(94)90144‐9 ↗
63. 10.21769/BioProtoc.260810.21769/BioProtoc.2608 ↗
64. 10.1007/s00213‐020‐05652‐310.1007/s00213‐020‐05652‐3 ↗
65. 10.1016/j.biopsych.2009.11.00710.1016/j.biopsych.2009.11.007 ↗
66. 10.1016/j.neuropharm.2020.10799110.1016/j.neuropharm.2020.107991 ↗
67. 10.1177/033310241773820210.1177/0333102417738202 ↗